John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal manage- ment and risk factors for death. Clin Infect Dis. 1998;26:1302 1309. 129. Stanton BF, Baltimore RS, Clemens JD. Changing spectrum of infec- tive endocarditis in children: analysis of 26 cases, 1970-1979. Am J Dis Child. 1984;138:720 725. 130. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardiothorac Surg. 1994;8:420 424. 131. Wolff M, Witchitz S, Chastang C, R gnier B, Vachon F. Prosthetic valve endocarditis in the ICU: prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest. 1995;108:688 694. 132. Geraci JE, Wilson WR. Symposium on infective endocarditis, III: en- docarditis due to gram-negative bacteria: report of 56 cases. Mayo Clin Proc. 1982;57:145 148. 133. Baddour LM. Long-term suppressive therapy for Candida parapsilosis- induced prosthetic valve endocarditis. Mayo Clin Proc. 1995;70:773 775. doi: 10.1016/S0025-6196(11)64350-4. 134. Castiglia M, Smego RA, Sames EL. Candida endocarditis and ampho- tericin B intolerance: potential role for fluconazole. Infect Dis Clin Pract. 1994;3:248 53. 135. Wilson WR, Danielson GK, Giuliani ER, Washington JA 2nd, Jaumin PM, Geraci JE. Cardiac valve replacement in congestive heart failure due to infective endocarditis. Mayo Clin Proc. 1979;54:223 226. 136. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation. 1978;58:589 597. 137. Stinson EB. Surgical treatment of infective endocarditis. Prog Cardiovasc Dis. 1979;22:145 168. 138. Croft CH, Woodward W, Elliott A, Commerford PJ, Barnard CN, Beck W. Analysis of surgical versus medical therapy in active complicated na- tive valve infective endocarditis. Am J Cardiol. 1983;51:1650 1655. 139. Omari B, Shapiro S, Ginzton L, Robertson JM, Ward J, Nelson RJ, Bayer AS. 